| Senior Manager |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
Sep 03, 2024 |
| 349145BR - Director, Channel Enablement and Optimization Governance |
East Hanover |
USA |
US |
Innovative Medicines |
Marketing |
Sep 13, 2024 |
| Senior Analyst- US Pharma Analytics |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
Sep 16, 2024 |
| Head of Data Driven Decision Making |
New South Wales (NSW) |
Australia |
International |
Innovative Medicines |
Marketing |
Sep 19, 2024 |
| Digital Strategy & Insights Manager (f/m/d) |
Vienna |
Austria |
International |
Innovative Medicines |
Marketing |
Sep 20, 2024 |
| Brand manager - Oncology (m/f/d) / Vodja blagovne znamke v onkologiji (m/ž/d) |
Ljubljana |
Slovenia |
International |
Innovative Medicines |
Marketing |
Sep 20, 2024 |
| Patient Support Program Lead |
Seoul |
South Korea |
International |
Innovative Medicines |
Marketing |
Sep 24, 2024 |
| Manager, MarTech |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
Sep 24, 2024 |
| Sr. TA Strategy Lead (Renal Therapy Area) |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Marketing |
Aug 07, 2024 |
| Director HSPD Asset Lead and Expert |
London (The Westworks) |
Switzerland |
International |
Innovative Medicines |
Marketing |
Sep 03, 2024 |
| Director, Process Effectiveness & Reporting |
East Hanover |
USA |
US |
Innovative Medicines |
Marketing |
Sep 03, 2024 |
| Manager - Field Effectiveness |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
Sep 03, 2024 |
| ASCVD Brand Manager |
Seoul |
South Korea |
International |
Innovative Medicines |
Marketing |
Sep 03, 2024 |
| Senior Manager, Marketing- Cardiovascular |
Makati City |
Philippines |
International |
Innovative Medicines |
Marketing |
Sep 05, 2024 |
| Manager Data Science |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
Sep 06, 2024 |
| Manager Data Science |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
Sep 09, 2024 |
| Team Leader |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
Sep 03, 2024 |
| Product manager (Immunology) |
Moscow (City) |
Russian Fed. |
International |
Innovative Medicines |
Marketing |
Iul 04, 2024 |
| RLT HCS & Partnerships Head |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Marketing |
Sep 03, 2024 |
| Senior Analyst - Competitive Social Intelligence |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
Aug 30, 2024 |
| Data Steward |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
Oct 24, 2024 |
| Brand Manager Cardiovascular - Tempo Determinato |
Milano |
Italy |
International |
Innovative Medicines |
Marketing |
Oct 25, 2024 |
| (高级)区域市场经理 |
Chengdu (Sichuan Province) |
China |
International |
Innovative Medicines |
Marketing |
Oct 25, 2024 |
| Director, NPS Analytics - CRM |
East Hanover |
USA |
US |
Innovative Medicines |
Marketing |
Oct 25, 2024 |
| Director, Product Strategy Lead, Urology/Prostate |
East Hanover |
USA |
US |
Innovative Medicines |
Marketing |
Oct 25, 2024 |
| Solution Design |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Marketing |
Sep 03, 2024 |
| TA Strategy Lead - GenMed |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Marketing |
Oct 02, 2024 |
| CX strategy |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Marketing |
Oct 04, 2024 |
| TA Strategy Lead, RLT (Prostate Cancer) |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Marketing |
Oct 07, 2024 |
| Lead, Integrated Insights & Planning_市場調査 |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Marketing |
Oct 07, 2024 |
| Analyst - SFE Products |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
Mai 20, 2024 |
| Analyst - SFE Products |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
Mai 20, 2024 |
| Associate Marketing |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Marketing |
Iul 08, 2024 |
| 区域市场组经理 |
Xian (Shanxi Province) |
China |
International |
Innovative Medicines |
Marketing |
Iul 28, 2024 |
| (高级)区域市场经理 |
Xian (Shanxi Province) |
China |
International |
Innovative Medicines |
Marketing |
Sep 05, 2024 |
| (高级)地区经理 |
Hefei (Anhui Province) |
China |
International |
Innovative Medicines |
Marketing |
Sep 12, 2024 |
| Senior Area Marketing Manager |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Marketing |
Oct 15, 2024 |
| Financial Accounting Specialist (m/w/d) |
Schaftenau |
Austria |
Finance |
CTS |
Audit & Finance |
Sep 13, 2024 |
| Tax Manager m/w/d) |
Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) |
Germany |
Finance |
Corporate |
Audit & Finance |
Oct 16, 2024 |
| Corporate Tax Manager |
Amiria |
Egypt |
Finance |
Corporate |
Audit & Finance |
Mai 31, 2024 |
| P2P & T&E Specialist (Japanese speaker) |
Selangor |
Malaysia |
Finance |
CTS |
Audit & Finance |
Iun 05, 2024 |
| P2P & T&E Business Partner (Japanese speaker) |
Selangor |
Malaysia |
Finance |
CTS |
Audit & Finance |
Iun 12, 2024 |
| R2R Senior Specialist GL & Reporting |
Selangor |
Malaysia |
Finance |
CTS |
Audit & Finance |
Iun 13, 2024 |
| Global Digital FRA Automation Lead |
Hyderabad (Office) |
India |
Finance |
Corporate |
Audit & Finance |
Iun 20, 2024 |
| Senior Financial Reporting and Accounting Specialist |
Prague |
Czech Republic |
Finance |
CTS |
Audit & Finance |
Iul 03, 2024 |
| Tax Specialist (m/w/d) |
Schaftenau |
Austria |
Finance |
CTS |
Audit & Finance |
Iul 22, 2024 |
| Vodja Finančne skladnosti in kontrol Slovenija (m/ž/d) / Financial Control and Compliance Lead Slovenia (m/f/d) |
Ljubljana |
Slovenia |
Finance |
CTS |
Audit & Finance |
Oct 17, 2024 |
| Associate Director, M&A Planning & Integration |
East Hanover |
USA |
Finance |
Corporate |
Audit & Finance |
Oct 17, 2024 |
| R2R Senior Specialist - Inventory |
Selangor |
Malaysia |
Finance |
CTS |
Audit & Finance |
Oct 02, 2024 |
| Site Finance Head |
Morris Plains |
USA |
Finance |
Innovative Medicines |
Audit & Finance |
Oct 04, 2024 |